Pacific Bio (PACB) Misses Q2 EPS by 2c
Pacific Bio (NASDAQ: PACB) reported Q2 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Pacific Bio (PACB) click here.
Pacific Bio (NASDAQ: PACB) reported Q2 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Pacific Bio (PACB) click here.